C(P(CCCC)CCCC)CCC.CN(C(/N=N/C(N(C)C)=O)=O)C.C([O:29][C:30]1[C:35]([CH3:36])=[C:34]([C:37]2[O:38][C:39]3[CH:45]=[CH:44][C:43](O)=[CH:42][C:40]=3[CH:41]=2)[O:33][C:32](=[O:47])[C:31]=1[CH3:48])(=O)C.[OH:49][CH2:50][C:51]1[CH:52]=[N:53][CH:54]=[N:55][CH:56]=1.[OH-].[Li+].Cl>C1COCC1.C(Cl)Cl.CCOC(C)=O>[CH3:48][C:31]1[C:32](=[O:47])[O:33][C:34]([C:37]2[O:38][C:39]3[CH:45]=[CH:44][C:43]([O:49][CH2:50][C:51]4[CH:52]=[N:53][CH:54]=[N:55][CH:56]=4)=[CH:42][C:40]=3[CH:41]=2)=[C:35]([CH3:36])[C:30]=1[OH:29]A solution of tributylphosphine in 2 N THF (0.94 ml) and a solution of TMAD (323 mg) in CH2Cl2 (3 ml) were added dropwise to a solution of 4-acetyloxy-3,5-dimethyl-6-(5-hydroxybenzofuran-2-yl)-2H-pyran-2-one (118 mg) and 5-hydroxymethylpyrimidine (202 mg) in THF (30 ml) at 0° C., and the mixture was stirred at room temperature overnight. The reaction solution was cooled on ice, a 1 N lithium hydroxide aqueous solution (5 ml) was added and the mixture was stirred at room temperature for one hour, after which the reaction solution was again cooled on ice, a 1 N hydrochloric acid aqueous solution (5 ml) and AcOEt were added, the organic layer and aqueous layer were separated, and the aqueous layer was further extracted with AcOEt. The organic layers were combined and dried with MgSO4, and then filtered and concentrated. The residue was purified by silica gel column chromatography (AcOEt/MeOH=10/1) to obtain 3,5-dimethyl-4-hydroxy-6-(5-(5-pyrimidinylmethoxy)benzofuran-2-yl)-2H-pyran-2-one.
불러오는 중…